PBYI
Puma Biotechnology, Inc.
9.70$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -622.7% | -9.6% | 8.2% | 0.4% | 8.2% | -6.9% | 11.5% | 16.9% | 18.3% | |
| – | – | – | 10.1% | 2.9% | 3.0% | 4.5% | 4.5% | 4.3% | 4.9% | 5.0% | 4.8% | |
| – | – | – | 392.5% | 34.6% | 21.1% | 16.2% | 12.9% | 5.2% | 4.3% | 3.6% | 3.0% | |
| – | – | – | 392.5% | 34.8% | 24.5% | 16.7% | 15.7% | 8.3% | – | – | – | |
| – | – | – | 28.7% | -2.0% | 8.6% | 5.8% | -0.5% | -19.5% | -7.6% | -1.5% | -4.4% | |
| – | – | – | 182.1% | 0.2% | 0.1% | 8.9% | 0.0% | 3.1% | 5.4% | 0.0% | 0.0% | |
| – | – | – | -55.6% | -22.9% | 1.9% | 10.4% | -4.3% | 3.1% | -8.1% | -8.9% | -15.8% | |
| – | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | 96.3% | 3.0% | 0.5% | 0.0% | – | 5.4% | – | – | – | |
| – | – | – | 174.8% | 40.2% | -25.1% | -0.7% | -0.6% | 0.0% | 0.0% | -14.5% | -19.5% | |
| – | – | – | 271.1% | 43.2% | -24.6% | 0.0% | -12.6% | 5.4% | 1.0% | -14.7% | -19.8% | |
| – | – | – | -407.2% | 10.6% | -14.5% | 10.8% | -8.8% | 1.5% | 3.3% | -6.7% | -17.3% | |
| – | – | – | -804.8% | -9.8% | 8.1% | -8.5% | 8.2% | -10.0% | 6.1% | 16.9% | 18.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.